Cecchin, Diego https://orcid.org/0000-0001-7956-1924
Zorz, Alessandra
Lhommel, Renaud
Flaus, Anthime
Tylski, Perrine
Mathoux, Gregory
Hartman, Neil
Guedj, Eric
Serani, Francesca
Imbert, Laetitia
Verger, Antoine
Article History
Received: 30 April 2025
Accepted: 16 December 2025
First Online: 28 December 2025
Declarations
:
: Financial interests : Cecchin D. has received speaker and consultant honoraria from GE healthcare, Eli Lilly and Life Molecular Imaging. Verger A. has received speaker and consultant honoraria from Curium, GE healthcare and Eisai. Imbert L. has received speaker honoraria from Spectrum Dynamics Medical. Guedj E. has received consultant honoraria from GE healthcare, Life Molecular Imaging, Keosys, Curium, and AAA/Novartis. The other authors have no relevant financial or non-financial interests to disclose.
: This study is a consensus between experts in Europe on acquisition and reconstruction parameters to be used in new CZT 3D systems. We have compared our standard clinical practice (already established in each center) confirming results in phantom acquisitions when needed. As such ethical approval was not deemed necessary.